首页 | 本学科首页   官方微博 | 高级检索  
     


Health economic models in hemophilia A and utility assumptions from a clinician's perspective
Authors:Michele Valente  Paolo A. Cortesi PhD  Giuseppe Lassandro MD  Prasad Mathew MD  Jennifer Pocoski PharmD  MPH  Angelo C. Molinari MD  Lorenzo G. Mantovani DSc  Paola Giordano MD
Affiliation:1. Bocconi University, Milano, Italy;2. Bayer HEOR Intern, Whippany, New Jersey;3. Research Centre on Public Health (CESP), University of Milan‐Bicocca, Monza, Italy;4. Department of Biomedical Science and Human Oncology‐Pediatric Unit, University of Bari “Aldo Moro,”, Bari, Italy;5. Bayer HealthCare Pharmaceuticals, Whippany, New Jersey;6. University of New Mexico, Albuquerque, New Mexico;7. Department of Hematology and Oncology, Thrombosis and Hemostasis Unit, Giannina Gaslini Children's Hospital, Genoa, Italy
Abstract:
Keywords:Cost Utility Analysis (CUA)  Health Technology Assessment (HTA)  Health‐related quality of life (HRQoL)  Hemophilia  Prophylaxis  Quality‐adjusted life years (QALY)
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号